MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Macrogenics (MGNX) Tops Q2 EPS by 19c
August 7, 2018 5:00 PM EDTMacrogenics (NASDAQ: MGNX) reported Q2 EPS of ($1.03), $0.19 better than the analyst estimate of ($1.22). Revenue for the quarter came in at $18.8 million versus the consensus estimate of $4.21 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
... More